Stay updated on Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial.
Sign up to get notified when there's something new on the Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial. page.

Latest updates to the Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial. page
- Check6 days agoChange DetectedAdded and updated core trial status fields: Completed as the new Study Status, with Recruitment Status and updated Contacts/Locations. These changes reflect the trial's current operational state and contact information.SummaryDifference0.3%

- Check13 days agoChange DetectedThe page history shows a new Revision: v3.4.2 replacing v3.4.1, a routine maintenance update that does not affect study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedOn 2026-02-04, References, IPDSharing, and Study Status were added with Revision v3.4.1. The older Revision v3.4.0 from 2025-09-23 was removed.SummaryDifference0.3%

- Check27 days agoChange DetectedUI/UX updates on the history page include a glossary toggle, green/red highlights for additions/deletions, and new revision metadata (No FEAR Act data and Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; this is a system-level update and does not affect page content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page history now includes a new Revision: v3.3.3 entry. Entries for HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

Stay in the know with updates to Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial. page.